Fundz

Iantrek, Inc. raised $42M in Series C funding, led by U.S. Venture Partners, to support the U.S. commercial launch of AlloFlo™ Uveo and expand its product pipeline.

PRIVATEAug 20, 2025

Amount Raised

$42 Million

Round Type

Series C

White PlainsBiotechnology

Investors

Visionary VenturesaMoon FundRadius Special Situations FundSectoral Asset ManagementCivilization VenturesU.S. Venture Partners

Description

Iantrek, Inc, a White Plains, NY-based bio-interventional ophthalmic surgery company, closed a $42M Series C financing. The round was led by US Venture Partners, with contributions from aMoon Fund and existing investors. The funds will facilitate the US commercial launch of AlloFlo™ Uveo and support broader pipeline expansion. Iantrek is also progressing towards the commercial launch of its next bio-interventional product in 2026.

Quick answer

Iantrek raised $42 Million in a Series C round, dated August 20, 2025. Investors: Visionary Ventures, aMoon Fund, Radius Special Situations Fund, Sectoral Asset Management, Civilization Ventures and U.S. Venture Partners. Iantrek is based in White Plains, New York, United States.

How much did Iantrek raise?
Iantrek raised $42 Million in a Series C round on August 20, 2025.
Who invested in Iantrek?
Visionary Ventures, aMoon Fund, Radius Special Situations Fund, Sectoral Asset Management, Civilization Ventures and U.S. Venture Partners are named as investors in this round.
What does Iantrek do?
Iantrek, Inc. is a medical technology company founded by ophthalmic innovator Dr. Tsontcho Ianchulev, which is focused on micro- and bio-interventional solutions to advance the surgical treatment of chronic eye diseases.
Where is Iantrek based and how big is it?
Iantrek is based in White Plains, New York, United States. Fundz records about 49 employees.
Who are the decision-makers at Iantrek?
Fundz holds 2 contacts at Iantrek. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology around the same time

Companies in the same sectors as Iantrek that raised within 45 days of this round, from Fundz verified event records.

  • Innventure raised $9.8M on October 3, 2025.
  • Motor City Dental Partners raised an undisclosed amount (Debt Financing) on October 2, 2025.
  • Leyden Labs raised $35M (Funding Round) on October 2, 2025.
  • OncoC4 raised $50M (Series B) on October 2, 2025.
  • Kihealth raised $5M (Seed) on October 2, 2025.
  • Cartography Biosciences raised $67M (Series B) on October 2, 2025.

Who to call at Iantrek, and when

A new round usually means Iantrek is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Iantrek raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Iantrek, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Iantrek. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Iantrek

Location

151 EAST POST ROAD

White Plains, New York, United States

About

Iantrek, Inc. is a medical technology company founded by ophthalmic innovator Dr. Tsontcho Ianchulev, which is focused on micro- and bio-interventional solutions to advance the surgical treatment of chronic eye diseases. The company has developed a comprehensive late-stage portfolio for ophthalmic interventions and is advancing next-generation micro-surgical instrumentation and biologic tissue solutions for surgeons and patients.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Iantrek raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Verified contacts7 people are listed at Iantrek. We don't have their email yet.See plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Iantrek's next move

See what Strategic adds

Iantrek raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.